Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations

Molecular Therapy

Volumn 8, Issue 2, 2003, Pages 332-341

  Escarpe, Paul ^a   Zayek, Nathalie ^a   Chin, Peggy ^a   Borellini, Flavia ^a   Zufferey, Romain ^a   Veres, Gabor ^a   Kiermer, Veronique ^a  

^a CELL GENESYS INC   (United States)

Author keywords

Biological assay; Gene therapy; Lentiviral vectors; Safety; Virus replication

Indexed keywords

LENTIVIRUS VECTOR; RETROVIRUS VECTOR;

ARTICLE; BIOASSAY; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENE AMPLIFICATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; RATING SCALE; SCREENING TEST; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS DETECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0041854294     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00167-9     Document Type: Article

References (31)

1. Trono, D. (2000). Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther. 7: 20-23.
2. Naldini, L., and Verma, I. M. (2000). Lentiviral vectors. Adv. Virus Res. 55: 599-609.
3. Ailles, L., et al. (2002). Molecular evidence of a lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. Mol. Ther. 6: 615-626.
4. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
5. Horn, P. A., et al. (2002). Lentivirus-mediated gene transfer into hematopoietic repopulating bells in baboons. Gene Ther. 1464-1471.
6. VandenDriessche, T., et al. (2002). Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100: 813-822.
7. Lois, C., Hong, E. J., Pease, S., Brown, E. J., and Baltimore, D. (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872.
8. Donahue, R. E., et al. (1992). Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176: 1125-1135.
9. Dull, T., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471.
10. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15: 871-875.
11. Zufferey, R., et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72: 9873-9880.
12. Wilson, C. A., Ng, T.-H., and Miller, A. D. (1997). Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors. Hum. Gene Ther. 8: 869-874.
13. Chen, J., Reeves, L., and Cornetta, K. (2001). Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors. Hum. Gene Ther. 12: 61-70.
14. Forestell, S. P., Dando, J. S., Bohnlein, E., and Rigg, R. J. (1996). Improved detection of replication-competent retrovirus. J. Virol. Methods 60: 171-178.
15. Farson, D., et al. (2001). A new-generation stable inducible packaging cell line for lentiviral vectors. Hum. Gene Ther. 12: 981-997.
16. Miller, A. D., Law, M. F., and Verma, I. M. (1985). Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell. Biol. 5: 431-437.
17. Richmond, J. Y., and McKinney, R. W. (1999). Biosafety in Microbiological and Biomedical Laboratories. Centers for Disease Control, National Institutes of Health, Washington, DC.
18. + T lymphocytes. J. Virol. 66: 6489-6495.
19. Bhat, N. K., Adachi, Y., Samuel, K. P., and Derse, D. (1993). HTLV-1 gene expression by defective proviruses in an infected T-cell line. Virology 196: 15-24.
20. Cheng, H., Tarnok, J., and Parks, W. P. (1998). Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. J. Virol. 72: 6911-6916.
21. Zimmermann, K., et al. (1991). Trans-activation of the HIV-1 LTR by the HIV-1 Tat and HTLV-1 Tax proteins is mediated by different cis-acting sequences. Virology 182: 874-878.
22. Jeang, K. T., Widen, S. G., Semmes, O. J., and Wilson, S. H. (1990). HTLV-1 transactivator protein, tax, is a trans-repressor of the beta-polymerase gene. Science 247: 1082-1084.
23. Bukovsky, A., Song, J.-P., and Naldini, L. (1999). Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J. Virol. 73: 7087-7092.
24. Haas, D. L., Case, S. S., Crooks, G. M., and Kohn, D. B. (2000). Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol. Ther. 2: 71-80.
25. + cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice. Mol. Ther. 7: 317-324.
26. Gallay, P., et al. (1996). Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70: 1027-1032.
27. + cells from patients with X-linked chronic granulomatous disease. Blood 13: 4381-4390.
28. Parker, S. D., Wall, J. S., and Hunter, E. (2001). Analysis of Mason-Pfizer monkey virus gag particles by scanning transmission electron microscopy. J. Virol. 75: 9543-9548.
29. Stromberg, K., Hurley, N. E., Davis, N. L., Rueckert, R. R., and Fleissner, E. (1974). Structural studies of avian myeloblastosis virus: comparison of polypeptides in virion and core component by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Virol. 13: 513-528.
30. Wilk, T., et al. (2001). Organization of immature human immunodeficiency virus type 1. J. Virol. 75: 759-771.
31. Dulbecco, R., and Ginsberg, H. S. (1988). Virology. Lippincott, Philadelphia.